Premium Nahrungsergänzungsmittel | artgerecht

Urea Cycle Disorder – Causes, Symptoms and Treatment

A urea cycle disorder is an inherited metabolic condition in which the body cannot properly convert ammonia into urea. This leads to toxic ammonia buildup in the blood, which can cause serious neurological damage.

Regular tips about health Regular tips about health

Things worth knowing about "Urea Cycle Disorder"

A urea cycle disorder is an inherited metabolic condition in which the body cannot properly convert ammonia into urea. This leads to toxic ammonia buildup in the blood, which can cause serious neurological damage.

What Is a Urea Cycle Disorder?

A urea cycle disorder (UCD) is an inherited metabolic disease caused by a deficiency of one or more enzymes involved in the urea cycle – a vital biochemical pathway that takes place primarily in the liver. The urea cycle converts toxic ammonia, a byproduct of protein breakdown, into urea, which is then safely excreted in the urine. When this cycle is disrupted, ammonia accumulates in the blood – a condition known as hyperammonemia – which can cause severe and potentially irreversible damage to the brain.

Causes

Urea cycle disorders are caused by mutations in genes encoding enzymes of the urea cycle. Most forms follow an autosomal recessive inheritance pattern, with the exception of OTC deficiency (ornithine transcarbamylase deficiency), which is X-linked and therefore tends to cause more severe disease in males.

The most common forms include:

OTC deficiency (ornithine transcarbamylase deficiency) – the most common form
CPS1 deficiency (carbamoyl phosphate synthetase 1 deficiency)
ASS deficiency (argininosuccinate synthetase deficiency, also known as citrullinemia type I)
ASL deficiency (argininosuccinate lyase deficiency, also known as argininosuccinic aciduria)
Arginase deficiency (argininemia)
NAGS deficiency (N-acetylglutamate synthase deficiency)

Symptoms

Symptoms vary depending on the specific enzyme affected, the severity of the defect, and the age of the individual. Newborns with severe enzyme deficiencies may develop a life-threatening hyperammonemic crisis within the first days of life.

Symptoms in Newborns

Poor feeding and vomiting
Lethargy and reduced consciousness
Seizures
Breathing abnormalities (hyperventilation)
Coma

Symptoms in Older Children and Adults (milder forms)

Recurrent headaches and vomiting, particularly after high-protein meals
Developmental delays and cognitive difficulties
Behavioral problems and irritability
Avoidance of protein-rich foods (often instinctive)
Episodes of confusion or altered consciousness

Diagnosis

Urea cycle disorders are diagnosed through a combination of clinical and laboratory investigations:

Newborn screening: Several forms (e.g., citrullinemia, argininosuccinic aciduria) are detectable through expanded newborn screening using tandem mass spectrometry.
Blood ammonia levels: Elevated ammonia is a key diagnostic finding.
Plasma amino acid analysis: Specific amino acid profiles help identify the affected enzyme.
Urinary orotic acid: Useful for distinguishing specific defects (e.g., elevated in OTC deficiency).
Molecular genetic testing: Identification of the causative gene mutation confirms the diagnosis.
Enzyme activity assay: Measurement of enzyme activity in liver tissue or blood samples.

Treatment

Treatment of urea cycle disorders aims to keep blood ammonia levels within a safe range and to prevent acute hyperammonemic crises. A multi-component approach is typically required:

Acute Management of Hyperammonemic Crisis

Immediate reduction of dietary protein intake
High-calorie intravenous glucose infusion to suppress protein catabolism
Administration of nitrogen scavengers (e.g., sodium benzoate, sodium phenylacetate/sodium phenylbutyrate) to enhance alternative nitrogen excretion pathways
Dialysis (hemodialysis) in severe cases

Long-Term Management

Protein-restricted diet with controlled amino acid intake and specialized amino acid formulas
Ongoing use of nitrogen scavenger medications (e.g., sodium benzoate, glycerol phenylbutyrate)
Arginine or citrulline supplementation depending on the specific defect
For NAGS deficiency: N-carbamylglutamate (carglumic acid) as a targeted therapy
Liver transplantation: Can largely correct the metabolic defect in severe cases, as the donor liver provides the missing enzyme activity

Prognosis

The outlook for individuals with urea cycle disorders depends on the severity of the enzyme deficiency, the timing of diagnosis, and the consistency of treatment. Patients diagnosed early and managed effectively can achieve a significantly improved quality of life. However, severe neonatal presentations with coma carry a risk of permanent neurological damage. Long-term follow-up at a specialized metabolic center is essential.

References

Häberle J et al. - Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. Journal of Inherited Metabolic Disease, 2019; 42(6): 1192-1230.
Summar ML, Tuchman M. - Proceedings of a consensus conference for the management of patients with urea cycle disorders. Journal of Pediatrics, 2001; 138(1 Suppl): S6-S10.
National Organization for Rare Disorders (NORD) - Urea Cycle Disorders. Available at: www.rarediseases.org (accessed 2024).

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category